Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genomics | 14 | 2022 | 5692 | 2.390 |
Why?
|
Pathology | 5 | 2018 | 272 | 2.110 |
Why?
|
Pathology, Molecular | 4 | 2021 | 325 | 1.980 |
Why?
|
Blood Transfusion | 12 | 2023 | 1296 | 1.440 |
Why?
|
Internship and Residency | 11 | 2022 | 5774 | 1.280 |
Why?
|
Erythrocyte Transfusion | 5 | 2023 | 565 | 1.120 |
Why?
|
Education, Medical, Graduate | 4 | 2021 | 2283 | 1.110 |
Why?
|
Cord Blood Stem Cell Transplantation | 7 | 2016 | 314 | 1.090 |
Why?
|
Educational Measurement | 5 | 2021 | 1206 | 1.030 |
Why?
|
Erythroblastosis, Fetal | 3 | 2022 | 60 | 1.010 |
Why?
|
Curriculum | 13 | 2022 | 3589 | 0.990 |
Why?
|
Pathology, Clinical | 4 | 2012 | 368 | 0.960 |
Why?
|
Blood Group Antigens | 2 | 2023 | 179 | 0.880 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2015 | 65 | 0.770 |
Why?
|
Blood Grouping and Crossmatching | 4 | 2022 | 106 | 0.760 |
Why?
|
Hemolysis | 1 | 2022 | 420 | 0.750 |
Why?
|
Isoantibodies | 5 | 2022 | 680 | 0.680 |
Why?
|
Blood Banks | 2 | 2010 | 110 | 0.670 |
Why?
|
Hematologic Diseases | 1 | 2022 | 498 | 0.660 |
Why?
|
Rho(D) Immune Globulin | 4 | 2022 | 34 | 0.620 |
Why?
|
Physicians | 7 | 2021 | 4554 | 0.610 |
Why?
|
Medical Oncology | 3 | 2021 | 2235 | 0.610 |
Why?
|
Rh Isoimmunization | 2 | 2015 | 21 | 0.590 |
Why?
|
Hospitalists | 1 | 2021 | 304 | 0.570 |
Why?
|
Fetal Blood | 5 | 2016 | 1317 | 0.550 |
Why?
|
Problem-Based Learning | 2 | 2018 | 359 | 0.540 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2763 | 0.520 |
Why?
|
Blood Specimen Collection | 2 | 2016 | 246 | 0.440 |
Why?
|
Clinical Competence | 11 | 2022 | 4681 | 0.430 |
Why?
|
Clinical Audit | 1 | 2011 | 31 | 0.400 |
Why?
|
Education, Medical, Undergraduate | 2 | 2018 | 1004 | 0.390 |
Why?
|
Emergency Medical Services | 1 | 2022 | 1914 | 0.380 |
Why?
|
Plasma Exchange | 1 | 2011 | 155 | 0.380 |
Why?
|
Blood Component Transfusion | 1 | 2011 | 142 | 0.370 |
Why?
|
Erythrocytes | 5 | 2023 | 2452 | 0.360 |
Why?
|
Needs Assessment | 5 | 2021 | 1146 | 0.360 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.360 |
Why?
|
Platelet Transfusion | 3 | 2013 | 314 | 0.360 |
Why?
|
Pregnancy Complications | 3 | 2015 | 2861 | 0.340 |
Why?
|
Blood Group Incompatibility | 2 | 2023 | 145 | 0.330 |
Why?
|
Graft Survival | 4 | 2009 | 3733 | 0.320 |
Why?
|
Laboratories, Hospital | 1 | 2009 | 194 | 0.310 |
Why?
|
Internal Medicine | 1 | 2014 | 1009 | 0.300 |
Why?
|
Boronic Acids | 1 | 2011 | 965 | 0.290 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2008 | 102 | 0.290 |
Why?
|
Quality Control | 1 | 2010 | 841 | 0.290 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2006 | 10 | 0.280 |
Why?
|
Humans | 64 | 2023 | 742088 | 0.270 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 1999 | 473 | 0.270 |
Why?
|
ABO Blood-Group System | 3 | 2023 | 367 | 0.270 |
Why?
|
Multiple Myeloma | 3 | 2020 | 5169 | 0.270 |
Why?
|
Pyrazines | 1 | 2011 | 1231 | 0.260 |
Why?
|
Computer Simulation | 1 | 2018 | 6191 | 0.250 |
Why?
|
Metalloendopeptidases | 2 | 2014 | 396 | 0.250 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2005 | 110 | 0.250 |
Why?
|
Trans-Activators | 6 | 2007 | 2924 | 0.240 |
Why?
|
Cell Separation | 2 | 2016 | 1749 | 0.240 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2005 | 131 | 0.230 |
Why?
|
Education | 2 | 2017 | 543 | 0.230 |
Why?
|
Blood Transfusion, Intrauterine | 1 | 2022 | 26 | 0.220 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2022 | 56 | 0.220 |
Why?
|
Hematopoietic Stem Cells | 2 | 2020 | 3381 | 0.220 |
Why?
|
Blood Component Removal | 1 | 2022 | 125 | 0.200 |
Why?
|
von Willebrand Factor | 1 | 2005 | 668 | 0.190 |
Why?
|
Evidence-Based Medicine | 2 | 2010 | 3611 | 0.190 |
Why?
|
Schools, Medical | 2 | 2021 | 878 | 0.190 |
Why?
|
Online Systems | 1 | 2020 | 184 | 0.180 |
Why?
|
Cell Nucleus | 3 | 1999 | 2968 | 0.170 |
Why?
|
Review Literature as Topic | 3 | 2011 | 333 | 0.170 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1967 | 0.170 |
Why?
|
Education, Medical | 2 | 2010 | 1717 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2023 | 685 | 0.150 |
Why?
|
Membrane Transport Proteins | 1 | 2023 | 1028 | 0.150 |
Why?
|
DNA-Binding Proteins | 6 | 2004 | 9639 | 0.140 |
Why?
|
Biomedical Research | 2 | 2017 | 3306 | 0.140 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 281 | 0.130 |
Why?
|
Transplantation, Homologous | 2 | 2023 | 4771 | 0.130 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2123 | 0.130 |
Why?
|
Preceptorship | 1 | 2016 | 61 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9274 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2016 | 5425 | 0.130 |
Why?
|
Financing, Organized | 1 | 2017 | 202 | 0.130 |
Why?
|
von Willebrand Diseases | 1 | 2017 | 127 | 0.130 |
Why?
|
Models, Educational | 1 | 2018 | 377 | 0.130 |
Why?
|
Thrombelastography | 1 | 2017 | 163 | 0.130 |
Why?
|
Data Collection | 2 | 2014 | 3339 | 0.130 |
Why?
|
Fetus | 1 | 2022 | 1879 | 0.130 |
Why?
|
Kell Blood-Group System | 1 | 2014 | 22 | 0.130 |
Why?
|
Infant, Newborn | 5 | 2022 | 25575 | 0.120 |
Why?
|
Transplantation Chimera | 2 | 2007 | 612 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2015 | 587 | 0.120 |
Why?
|
Microbiological Techniques | 1 | 2014 | 102 | 0.110 |
Why?
|
Educational Status | 1 | 2021 | 2533 | 0.110 |
Why?
|
Anesthesiology | 1 | 2022 | 1043 | 0.110 |
Why?
|
Hematology | 1 | 2015 | 219 | 0.110 |
Why?
|
Blood Preservation | 1 | 2013 | 177 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3585 | 0.100 |
Why?
|
Australia | 1 | 2014 | 1167 | 0.100 |
Why?
|
Anesthesia | 1 | 2022 | 1548 | 0.100 |
Why?
|
Pregnancy | 4 | 2022 | 29087 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13655 | 0.090 |
Why?
|
Delphi Technique | 1 | 2013 | 778 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4420 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 839 | 0.090 |
Why?
|
Histocompatibility Testing | 2 | 2009 | 742 | 0.090 |
Why?
|
Canada | 1 | 2014 | 2061 | 0.090 |
Why?
|
United States | 6 | 2022 | 69693 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2007 | 504 | 0.080 |
Why?
|
STAT1 Transcription Factor | 3 | 1999 | 320 | 0.080 |
Why?
|
Biostatistics | 1 | 2010 | 160 | 0.080 |
Why?
|
Vanadates | 2 | 1999 | 82 | 0.080 |
Why?
|
Epitopes | 1 | 2015 | 2569 | 0.080 |
Why?
|
Quality Assurance, Health Care | 2 | 2017 | 2211 | 0.080 |
Why?
|
Europe | 1 | 2014 | 3339 | 0.080 |
Why?
|
Macrocyclic Compounds | 1 | 2007 | 72 | 0.080 |
Why?
|
Coloring Agents | 1 | 2010 | 565 | 0.080 |
Why?
|
Receptors, Complement 3b | 1 | 2007 | 145 | 0.080 |
Why?
|
Histocompatibility | 1 | 2009 | 330 | 0.080 |
Why?
|
Erythroblasts | 1 | 2007 | 150 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2281 | 0.070 |
Why?
|
Staurosporine | 2 | 1999 | 251 | 0.070 |
Why?
|
Program Evaluation | 1 | 2016 | 2485 | 0.070 |
Why?
|
Students, Medical | 2 | 2018 | 1858 | 0.070 |
Why?
|
Plasma | 1 | 2010 | 575 | 0.070 |
Why?
|
Blood Cells | 1 | 2008 | 309 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2007 | 212 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1705 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3915 | 0.070 |
Why?
|
Immunoglobulin Light Chains | 1 | 2007 | 276 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1786 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3462 | 0.070 |
Why?
|
Medical Order Entry Systems | 1 | 2011 | 544 | 0.070 |
Why?
|
Mycophenolic Acid | 1 | 2007 | 343 | 0.070 |
Why?
|
Training Support | 1 | 2006 | 113 | 0.070 |
Why?
|
Resource Allocation | 1 | 2008 | 341 | 0.070 |
Why?
|
Attitude | 1 | 2010 | 772 | 0.060 |
Why?
|
Myeloablative Agonists | 1 | 2006 | 218 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1658 | 0.060 |
Why?
|
Chimerism | 1 | 2006 | 158 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7276 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2008 | 2513 | 0.060 |
Why?
|
Transplantation Conditioning | 2 | 2010 | 1597 | 0.060 |
Why?
|
Alleles | 1 | 2015 | 6931 | 0.060 |
Why?
|
ADAM Proteins | 1 | 2005 | 242 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 500 | 0.060 |
Why?
|
Boston | 2 | 2014 | 9305 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4801 | 0.060 |
Why?
|
Publishing | 1 | 2010 | 833 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2015 | 4554 | 0.050 |
Why?
|
Female | 13 | 2022 | 379592 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2006 | 780 | 0.050 |
Why?
|
Graft vs Host Disease | 3 | 2009 | 2951 | 0.050 |
Why?
|
Antigens | 1 | 2007 | 1462 | 0.050 |
Why?
|
Thromboembolism | 1 | 2008 | 983 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2023 | 270 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2004 | 617 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15194 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2007 | 802 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3839 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2002 | 440 | 0.050 |
Why?
|
Adult | 9 | 2021 | 213712 | 0.050 |
Why?
|
Genotype | 1 | 2015 | 12946 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2002 | 1723 | 0.040 |
Why?
|
Vasculitis | 1 | 2004 | 521 | 0.040 |
Why?
|
Career Choice | 1 | 2006 | 743 | 0.040 |
Why?
|
Interferon-gamma | 2 | 1999 | 3199 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8621 | 0.040 |
Why?
|
Phosphorylation | 3 | 1999 | 8436 | 0.040 |
Why?
|
Transfection | 3 | 2004 | 5892 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2010 | 1820 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 867 | 0.040 |
Why?
|
Monocytes | 1 | 2007 | 2593 | 0.040 |
Why?
|
Male | 11 | 2017 | 349538 | 0.040 |
Why?
|
Leupeptins | 1 | 1996 | 122 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2015 | 57683 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2002 | 1159 | 0.040 |
Why?
|
Receptors, Interferon | 1 | 1996 | 115 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2126 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2004 | 12071 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1996 | 457 | 0.030 |
Why?
|
Acetylcysteine | 1 | 1996 | 272 | 0.030 |
Why?
|
Cell Division | 1 | 2023 | 4564 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 9941 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4147 | 0.030 |
Why?
|
Middle Aged | 9 | 2016 | 213127 | 0.030 |
Why?
|
Cell Line | 4 | 2004 | 15994 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1801 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1996 | 563 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2016 | 77098 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2002 | 3278 | 0.030 |
Why?
|
Plateletpheresis | 1 | 2013 | 47 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1996 | 686 | 0.030 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 255 | 0.030 |
Why?
|
Transcription Factors | 2 | 2002 | 12164 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2004 | 7721 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2002 | 130 | 0.030 |
Why?
|
Cryopreservation | 1 | 2016 | 664 | 0.030 |
Why?
|
Organizational Policy | 1 | 2014 | 427 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7901 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 56350 | 0.030 |
Why?
|
Time Factors | 3 | 2013 | 40054 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15056 | 0.030 |
Why?
|
Kinetics | 1 | 1999 | 6474 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2016 | 764 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2002 | 3020 | 0.020 |
Why?
|
Neutrophils | 2 | 2016 | 3711 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 431 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 13853 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4214 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1996 | 1333 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 656 | 0.020 |
Why?
|
Tissue Donors | 2 | 2010 | 2205 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1999 | 2455 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11470 | 0.020 |
Why?
|
Immunization | 1 | 2014 | 1255 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6608 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3843 | 0.020 |
Why?
|
Dysmenorrhea | 1 | 2010 | 86 | 0.020 |
Why?
|
Teaching | 1 | 2017 | 1174 | 0.020 |
Why?
|
Color | 1 | 2010 | 306 | 0.020 |
Why?
|
Blotting, Western | 1 | 1996 | 5180 | 0.020 |
Why?
|
Transcriptional Activation | 2 | 2007 | 1782 | 0.020 |
Why?
|
Promoter Regions, Genetic | 3 | 2007 | 5867 | 0.020 |
Why?
|
Aged | 5 | 2017 | 162944 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 1999 | 3444 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2007 | 108 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1993 | 834 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2007 | 111 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 2009 | 547 | 0.020 |
Why?
|
Fibroblasts | 1 | 1996 | 4143 | 0.020 |
Why?
|
Mice | 6 | 2007 | 81045 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3800 | 0.020 |
Why?
|
Vidarabine | 1 | 2007 | 345 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 1999 | 5851 | 0.020 |
Why?
|
Autoimmunity | 1 | 2013 | 1348 | 0.020 |
Why?
|
DNA | 3 | 2007 | 7289 | 0.020 |
Why?
|
Melphalan | 1 | 2007 | 431 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2007 | 491 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 21596 | 0.020 |
Why?
|
Signal Transduction | 2 | 1999 | 23387 | 0.020 |
Why?
|
Survival Analysis | 2 | 2009 | 10248 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1831 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 740 | 0.020 |
Why?
|
Animals | 8 | 2010 | 168561 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1993 | 1837 | 0.020 |
Why?
|
Hysterectomy | 1 | 2010 | 927 | 0.010 |
Why?
|
Vaccines | 1 | 1993 | 817 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2266 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1993 | 2524 | 0.010 |
Why?
|
Child | 2 | 2022 | 77478 | 0.010 |
Why?
|
Smad3 Protein | 1 | 2004 | 180 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4886 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3769 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2002 | 27 | 0.010 |
Why?
|
Adolescent | 2 | 2009 | 85649 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 103 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 106 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 137 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 317 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 250 | 0.010 |
Why?
|
Tunica Intima | 1 | 2004 | 464 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 286 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1402 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2615 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2004 | 558 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1101 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 733 | 0.010 |
Why?
|
Hyperplasia | 1 | 2004 | 1183 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 914 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 644 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6891 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 1999 | 151 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 2049 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13814 | 0.010 |
Why?
|
Cell Lineage | 1 | 2007 | 2504 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 2335 | 0.010 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 1999 | 178 | 0.010 |
Why?
|
Blood Platelets | 1 | 2009 | 2506 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 18112 | 0.010 |
Why?
|
Patient Care Team | 1 | 2008 | 2527 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 2006 | 0.010 |
Why?
|
Societies, Medical | 1 | 2008 | 3740 | 0.010 |
Why?
|
Adipocytes | 1 | 2002 | 1182 | 0.010 |
Why?
|
Serine | 1 | 1999 | 828 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3293 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1263 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3770 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10163 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9387 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 912 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4751 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4553 | 0.010 |
Why?
|
Tyrosine | 1 | 1999 | 1460 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2837 | 0.010 |
Why?
|
Biological Transport | 1 | 1999 | 2119 | 0.010 |
Why?
|
Point Mutation | 1 | 1999 | 1624 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3869 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3493 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 13029 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 5979 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1993 | 642 | 0.010 |
Why?
|
Drosophila | 1 | 1999 | 1484 | 0.010 |
Why?
|
Rats | 1 | 2007 | 24265 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16665 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 1993 | 608 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2004 | 3119 | 0.010 |
Why?
|
Binding Sites | 1 | 1999 | 6115 | 0.010 |
Why?
|
Glucose | 1 | 2002 | 4391 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 62966 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1827 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16331 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2008 | 5304 | 0.010 |
Why?
|
Macrophages | 1 | 2004 | 5655 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2004 | 14554 | 0.010 |
Why?
|
Cryptococcosis | 1 | 1949 | 101 | 0.010 |
Why?
|
Cryptococcus neoformans | 1 | 1949 | 119 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 6096 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4933 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2002 | 19223 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11472 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 21821 | 0.000 |
Why?
|
Antibodies | 1 | 1993 | 2459 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5519 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2004 | 15244 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1993 | 3465 | 0.000 |
Why?
|